This is a routine insider sale of shares acquired from RSU vesting. The amount is immaterial relative to the company's market cap. No further action warranted; monitor for any unusual pattern of larger insider sales in future filings.
GILD drugs
GILD drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 9 $169.32entry
- T+1 · 7d ago +0.92%α +1.28% · $170.87
- T+5 · 15h ago −1.03%α +0.67% · $167.58
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Keeley Cain Wettan, an officer of Gilead Sciences, filed a Form 144 to sell 3,399 shares of common stock with an approximate market value of $569,570. The shares were acquired through vesting of restricted stock units between August and September 2026. The sale is a routine disposition of equity compensation by an insider, representing a negligible fraction of the company's $216.4B market cap.
Key Facts
- Insider: Keeley Cain Wettan, officer of Gilead Sciences
- Shares to be sold: 3,399 shares of common stock
- Estimated value: $569,570.43
- Shares acquired via vesting of restricted stock units from 08/10/2026 through 09/10/2026
- Filing date: 2026-11-06
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
Financial Impact
Sale of 3,399 shares worth ~$570K, representing ~0.00026% of Gilead's $216.4B market cap
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur
- No additional context on the insider's total holdings is provided to assess proportionality
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010782 |
| Document: 0001950047-26-010782-index.html | 0001950047-26-010782 |
| Document: 0001950047-26-010782.txt | 0001950047-26-010782 |
Track record
30 reports on GILD
5 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +22.38% at T+60 after the Aug 13, 2026 report. 5 of 8 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $167.58 Now $167.58 +0.00% settles Feb 16
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $167.71 Now $167.58 −0.08% settles Feb 12
- Nov 13, 20264d ago Court Ruling Bullish 4/10 Entry $170.99 Now $167.58 −1.99% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $168.08 Now $167.58 −0.30% settles Feb 11
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $170.87 Now $167.58 −1.93% settles Feb 8
- Nov 6, 202610d ago 144 Neutral 2/10 Viewing Entry $169.32 Now $167.58 −1.03% settles Feb 5
- Nov 4, 202612d ago 144 Neutral 3/10 Entry $167.57 Now $167.58 +0.01% settles Feb 3
- Oct 30, 202617d ago 144 Neutral 3/10 Entry $170.33 Now $167.58 −1.61% settles Jan 29
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $170.68 Now $167.58 −1.82% settles Jan 28
- Oct 22, 202625d ago Institutional Cluster Bearish 4/10 Entry $156.04 Now $167.58 −7.40% settles Jan 21
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers